Franke Axel, Lante Wolfgang, Zoeller Lothar G, Kurig Edmund, Weinhold Christian, Markewitz Andreas
Department of Cardiovascular Surgery, German Armed Forces Central Hospital, Ruebenacher Str. 170, D-56072 Koblenz, Germany.
Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):207-11. doi: 10.1510/icvts.2007.158899. Epub 2007 Nov 30.
HLA-DR expression on peripheral blood monocytes is reduced after cardiac surgery. Little is known about the reconstitution of HLA-DR expression on peripheral blood monocytes in patients suffering from early non-fatal perioperative complications. We conducted a prospective study to prove whether these complications adversely affect the recovery of HLA-DR expression. Before surgery (d0), on the first (d1), third (d3), fifth (5th) postoperative days, blood samples were collected from 90 patients who underwent elective cardiac surgery with cardiopulmonary bypass (CPB). HLA-DR expression was analysed flow cytometrically. Eleven patients experienced postoperative complications [mechanical ventilation of 24-48 h (n=6); reinstitution of CPB (n=2) intraoperatively; laparotomy (n=1), re-thoracotomy (n=1), re-intubation (n=1) within the first 24 h after surgery]. All patients showed a reduced HLA-DR expression after surgery with nadirs at d1 and d3. Whereas the values increased from d3 to d5 in patients with an uneventful clinical course, HLA-DR expression remained suppressed in patients with complications. HLA-DR expression is reduced after cardiac surgery with CPB. A delayed recovery of HLA-DR expression is seen in patients with early perioperative complications. These non-fatal complications appear to represent a 'second hit' resulting in a prolonged deficiency of the innate immune system. This might predispose to further infectious and septic complications.
心脏手术后外周血单核细胞上的HLA - DR表达降低。对于患有早期非致命围手术期并发症的患者,外周血单核细胞上HLA - DR表达的重建情况知之甚少。我们进行了一项前瞻性研究,以证明这些并发症是否会对HLA - DR表达的恢复产生不利影响。在手术前(d0)、术后第一天(d1)、第三天(d3)、第五天,从90例行体外循环(CPB)择期心脏手术的患者中采集血样。采用流式细胞术分析HLA - DR表达。11例患者出现术后并发症[机械通气24 - 48小时(n = 6);术中再次进行CPB(n = 2);剖腹手术(n = 1)、再次开胸手术(n = 1)、术后24小时内再次插管(n = 1)]。所有患者术后HLA - DR表达均降低,在d1和d3时降至最低点。临床过程平稳的患者其值从d3到d5升高,而有并发症的患者HLA - DR表达仍受抑制。CPB心脏手术后HLA - DR表达降低。围手术期早期出现并发症的患者可见HLA - DR表达恢复延迟。这些非致命并发症似乎代表一种“二次打击”,导致先天性免疫系统长期缺陷。这可能使患者更容易发生进一步的感染和脓毒症并发症。